Priorities for Improving the Management of Gastroenteropancreatic Neuroendocrine Tumors
Irvin M. Modlin(Yale University), Elizabeth G. Snyderwine, Steven F. Moss(Brown University), Daniel C. Chung(Massachusetts General Hospital), Robert T. Jensen(National Institutes of Health)
Cited by 226
Related Papers
Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
|Cell Host & Microbe|2013|2.7k
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
|Nature Medicine|2004|2k
Gastroenteropancreatic neuroendocrine tumours
|The Lancet Oncology|2008|1.8k
Celecoxib for the Prevention of Sporadic Colorectal Adenomas
|New England Journal of Medicine|2006|1k
The Chromosomal Instability Pathway in Colon Cancer
|Gastroenterology|2010|932